Inactive Instrument

Other languages Sigilon Therapeutics, Inc.

Equities

SGTX

US82657L2060

Other languages

Unlock all the news: Be the first to know and act before the market!

Eli Lilly : les rachats de Versanis et Sigilon sont bouclés	23-08-14
Eli Lilly Completes Purchase of Sigilon Therapeutics in Cash Deal	23-08-14
Sigilon Therapeutics, Inc. Announces Board Changes	23-08-11
Eli Lilly and Company completed the acquisition of remaining 91.56% stake in Sigilon Therapeutics, Inc. from Flagship Ventures Fund V, L.P. and Flagship Pioneering Special Opportunities Fund II, L.P., managed by Flagship Pioneering and others.	23-08-10
Sigilon Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
Aktien New York Schluss: Banken geben Dow Schwung - Nasdaq schwächelt	23-06-29
Sector Update: Health Care Stocks Advancing Late Thursday	23-06-29
Sector Update: Health Care Stocks Higher Thursday Afternoon	23-06-29
Top Midday Gainers	23-06-29
Top Stories at Midday: US Q1 GDP Revised Higher; Jobless Claims Post Surprise Drop; Powell Reiterates Comments; BioXcel Therapeutics Tumbles	23-06-29
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	23-06-29
Sector Update: Health Care	23-06-29
Traders Cheer After Bank Stress Test Results, Lifting US Equity Futures	23-06-29
Eli Lilly and : attendu en hausse après l'annonce du rachat de Sigilon Therapeutics	23-06-29
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments	23-06-29
Top Premarket Gainers	23-06-29
Eli Lilly to Acquire Sigilon Therapeutics in Deal Potentially Worth More Than $300 Million; Sigilon Shares Surge	23-06-29
Eli Lilly : accord pour l'acquisition de Sigilon Therapeutics	23-06-29
Eli Lilly to Buy Chronic Disease-focused Sigilon Therapeutics	23-06-29
Sigilon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sigilon Therapeutics, Inc.

Equities

SGTX

US82657L2060

Other languages

Filters